The symptoms and their severity vary between individuals
Gastrointestinal effects are among the most frequently reported adverse events with GLP-1 therapies and typically include nausea, vomiting, diarrhea, constipation, and abdominal pain
Diet and Exercise : Modifying your diet and increasing physical activity are critical components of diabetes management that can reduce or even eliminate the need for medication
Mounjaro is the brand name for tirzepatide, whose active ingredient is a different type of medication activating two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) that regulates energy balance in brain and fat cells
Body weight Larger bodies distribute semaglutide across more tissue
Sure, one may be more effective at weight loss (tirzepatide), but that doesnt make it inherently better. Plus, your healthcare provider is the best person to help you determine which medication makes the most sense for you